The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma

被引:1
作者
Che, XM
Natsugoe, S
Takao, S
Hokita, S
Tanabe, G
Baba, M
Kuroshima, K
Aikou, T
机构
[1] Kagoshima Univ, Sch Med, Dept Surg 1, Kagoshima 8908520, Japan
[2] Terada Hosp, Dept Surg, Kagoshima, Japan
关键词
p27; cyclin E; immunohistochemistry; advanced gastric carcinoma; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Cyclin E and p27 play opposing roles in the cell cycle. This study investigated the protein expression of p27 with cyclin E in the progression and prognosis of gastric carcinoma. METHODS. Of 241 patients with advanced gastric carcinoma, 38 had muscular layer invasion, 113 had subserosal layer invasion, and 90 had serosal invasion. Anti-p27 and cyclin E antibodies were used for immunohistochemical staining. RESULTS. Positive expression of p27 and cyclin E was 32.4% and 38.2%, respectively. Both p27 and cyclin E expression were related to histology of tumors but not to depth of invasion, lymph node metastasis, or stage grouping. A positive correlation was observed between p27 and cyclin E expression (P < 0.05). Tumors were divided into two groups according to the expression of cyclin E. Within the cyclin E positive tumors, the five-year survival rate was higher in patients with a p27 positive tumor than in those with a p27 negative tumor (P < 0.05). Patients with cyclin E positive tumors showing low expression of p27 had a poor prognosis. In cyclin E negative group tumors, no significant differences were observed irrespective of p27 expression. CONCLUSIONS. Reduced p27 expression is a negative prognostic factor for patients with cyclin E positive tumors. (C) 2000 American Cancer Society.
引用
收藏
页码:1214 / 1219
页数:6
相关论文
共 50 条
  • [1] Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients
    So, JBY
    Samarasinge, K
    Raju, GC
    Moochhala, SM
    Ti, TK
    JOURNAL OF SURGICAL RESEARCH, 2000, 94 (01) : 56 - 60
  • [2] The role of p27 in endometrial carcinoma
    Nycum, LR
    Smith, LM
    Farley, JH
    Kost, ER
    Method, MW
    Birrer, MJ
    GYNECOLOGIC ONCOLOGY, 2001, 81 (02) : 242 - 246
  • [3] Improved endometrial assessment using cyclin E and p27
    Dubowy, RL
    Feinberg, RF
    Keefe, DL
    Doncel, GF
    Williams, SC
    McSweet, JC
    Kliman, HJ
    FERTILITY AND STERILITY, 2003, 80 (01) : 146 - 156
  • [4] The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus
    Shibata, H
    Matsubara, O
    Wakiyama, H
    Tanaka, S
    PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (03) : 157 - 164
  • [5] p27, cyclin E, and CDK2 expression in normal and cancerous endometrium
    Oshita, T
    Shigemasa, K
    Nagai, N
    Ohama, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (04) : 737 - 743
  • [6] Prognostic value of cyclin E and p53 expression in gastric carcinoma
    Sakaguchi, T
    Watanabe, A
    Sawada, H
    Yamada, Y
    Yamashita, J
    Matsuda, M
    Nakajima, M
    Miwa, T
    Hirao, T
    Nakano, H
    CANCER, 1998, 82 (07) : 1238 - 1243
  • [7] Expression of cyclin A, cyclin E and p27 in normal, hyperplastic and frankly malignant endometrial samples
    Gezginc, S. T.
    Celik, C.
    Dogan, N. U.
    Toy, H.
    Tazegul, A.
    Colakoglu, M. C.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (05) : 508 - 511
  • [8] The prognostic value of p27 in gastric cancer
    Wiksten, JP
    Lundin, J
    Nordling, S
    Kokkola, A
    von Boguslawski, K
    Haglund, C
    ONCOLOGY, 2002, 63 (02) : 180 - 184
  • [9] Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas
    Erlanson, M
    Landberg, G
    LEUKEMIA & LYMPHOMA, 2001, 40 (5-6) : 461 - 470
  • [10] The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes
    Pruneri, G
    Fracchiolla, N
    Cortelezzi, A
    Ponzoni, M
    Moisonneuve, P
    Lambertenghi-Deliliers, G
    HAEMATOLOGICA, 2003, 88 (01) : 109 - 110